BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15659134)

  • 1. Novel rescue therapy for C4d-positive acute humoral renal allograft rejection.
    Min L; Shuming J; Zheng T; Daxi J; Huiping C; Zhihong L; Leishi L
    Clin Transplant; 2005 Feb; 19(1):51-5. PubMed ID: 15659134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C4d-positive acute humoral renal allograft rejection: rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil.
    Liu M; Ji SM; Tang Zh; Ji DX; Chen HP; Liu ZH; Li LS
    Transplant Proc; 2004 Sep; 36(7):2101-3. PubMed ID: 15518760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil for C4d-positive acute humoral renal allograft rejection.
    Ji SM; Liu ZH; Chen JS; Sha GZ; Ji DX; Li LS
    Transplant Proc; 2006 Dec; 38(10):3459-63. PubMed ID: 17175303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients.
    Sun Q; Liu ZH; Yin G; Chen H; Chen J; Ji S; Li LS
    Nephrol Dial Transplant; 2006 Feb; 21(2):510-7. PubMed ID: 16421166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil.
    Sun Q; Liu ZH; Cheng Z; Chen J; Ji S; Zeng C; Li LS
    Kidney Int; 2007 Jan; 71(1):24-30. PubMed ID: 16969384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy.
    Schwarz C; Regele H; Huttary N; Wahrmann M; Exner M; Nagy-Bojarsky K; Kletzmayr J; Hörl WH; Böhmig GA
    Wien Klin Wochenschr; 2006 Jul; 118(13-14):397-404. PubMed ID: 16865644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption.
    Böhmig GA; Regele H; Exner M; Derhartunian V; Kletzmayr J; Säemann MD; Hörl WH; Druml W; Watschinger B
    J Am Soc Nephrol; 2001 Nov; 12(11):2482-2489. PubMed ID: 11675426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
    Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
    Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late developing C4d-positive humoral renal allograft rejection associated with withdrawal of mycophenolate mofetil.
    Sun Q; Tang Z; Chen J; Chen H; Liu Z; Li L
    Transplant Proc; 2005 Dec; 37(10):4244-5. PubMed ID: 16387089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation.
    Pascual M; Saidman S; Tolkoff-Rubin N; Williams WW; Mauiyyedi S; Duan JM; Farrell ML; Colvin RB; Cosimi AB; Delmonico FL
    Transplantation; 1998 Dec; 66(11):1460-4. PubMed ID: 9869086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation.
    Lederer SR; Friedrich N; Banas B; Welser G; Albert ED; Sitter T
    Clin Transplant; 2005 Apr; 19(2):168-74. PubMed ID: 15740551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of acute antidonor antibody-mediated humoral rejection after renal transplantation with specific consideration of serial graft biopsy histology.
    Shimizu T; Tokiwa M; Yamaguchi Y
    Clin Transplant; 2002; 16 Suppl 8():62-7. PubMed ID: 12464135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and late humoral rejection: a clinicopathologic entity in two times.
    Péfaur J; Díaz P; Panace R; Salinas P; Fiabane A; Quinteros N; Chea R; Naranjo E; Wurgaft A; Beltran E; Elgueta S; Wegmann ME; Gajardo JG; Contreras L
    Transplant Proc; 2008 Nov; 40(9):3229-36. PubMed ID: 19010241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
    Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients.
    Demirbaş A; Tuncer M; Yavuz A; Gürkan A; Kaçar S; Cetinkaya R; Tekin S; Akbaş SH; Akaydin M; Ersoy F; Yakupoğlu G
    Transplant Proc; 2004; 36(1):175-7. PubMed ID: 15013338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
    Gonwa T; Johnson C; Ahsan N; Alfrey EJ; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Leonhardt M; Fitzsimmons WE
    Transplantation; 2003 Jun; 75(12):2048-53. PubMed ID: 12829910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics.
    Crespo M; Pascual M; Tolkoff-Rubin N; Mauiyyedi S; Collins AB; Fitzpatrick D; Farrell ML; Williams WW; Delmonico FL; Cosimi AB; Colvin RB; Saidman SL
    Transplantation; 2001 Mar; 71(5):652-8. PubMed ID: 11292296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.
    Włodarczyk Z; Wałaszewski J; Perner F; Vitko S; Ostrowski M; Bachleda P; Kokot F; Klinger M; Szenohradsky P; Studenik P; Navratil P; Asztalos L; Rutkowski B; Nagy KK; Hickey D
    Ann Transplant; 2002; 7(3):28-31. PubMed ID: 12465429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation.
    Ibernón M; Gil-Vernet S; Carrera M; Serón D; Moreso F; Bestard O; Cruzado JM; Grinyó JM
    Transplant Proc; 2005 Nov; 37(9):3743-5. PubMed ID: 16386524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.